10x Genomics, Inc. provided revenue guidance for the full year 2024. 10x Genomics expects full year 2024 revenue to be in the range of $670 million to $690 million, representing 8% to 12% growth over full year 2023 revenue.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
25.99 USD | -1.52% | -5.42% | -53.56% |
May. 07 | Bruker's NanoString Secures Patent Case Win in Germany | MT |
May. 02 | North American Morning Briefing : Stock Futures -2- | DJ |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-53.56% | 3.11B | |
-1.29% | 12.64B | |
-0.47% | 8.46B | |
+5.68% | 5.66B | |
+22.61% | 5.27B | |
-2.03% | 4.49B | |
+19.30% | 2.87B | |
+33.07% | 2.31B | |
-8.42% | 2.23B | |
-3.55% | 1.89B |
- Stock Market
- Equities
- TXG Stock
- News 10x Genomics, Inc.
- 10X Genomics, Inc. Provides Revenue Guidance for the Full Year 2024